Cargando…

Impact of influenza vaccination on the risk of SARS-CoV-2 infection in a middle-aged group of people

Aims: An observational study of a retrospective cohort was performed to assess the impact of influenza vaccination (IV) on the risk of SARS-CoV-2 infection in a population of middle-aged people for 8 weeks after IV and compared with an unvaccinated group. Patients and methods: Data from 1098 middle-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bozek, Andrzej, Kozłowska, Renata, Galuszka, Beata, Grzanka, Alicja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095158/ https://www.ncbi.nlm.nih.gov/pubmed/33913801 http://dx.doi.org/10.1080/21645515.2021.1913961

Ejemplares similares

Acquired Angioedema in Selected Neoplastic Diseases
por: Zając, Magdalena, et al.
Publicado: (2023)

Different Development Forms of Local Allergic Rhinitis towards Birch
por: Bozek, Andrzej, et al.
Publicado: (2020)

Association between cancer and allergies
por: Kozłowska, Renata, et al.
Publicado: (2016)

The aspects of local allergic rhinitis in Polish children and adolescents
por: Bożek, Andrzej, et al.
Publicado: (2023)

Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial
por: Bożek, Andrzej, et al.
Publicado: (2017)

Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis
por: Bozek, Andrzej, et al.
Publicado: (2022)

Influenza vaccination in the time of SARS-CoV-2()
por: Reina, Jordi
Publicado: (2021)

SARS-CoV-2 and Influenza Vaccines in People with Excessive Body Mass—A Narrative Review
por: Drożdżyńska, Julia, et al.
Publicado: (2022)

The Effect of SARS-CoV-2 Virus Infection on the Course of Atopic Dermatitis in Patients
por: Miodońska, Martyna, et al.
Publicado: (2021)

Can atopy have a protective effect against cancer?
por: Bożek, Andrzej, et al.
Publicado: (2020)

SARS-CoV-2 vaccination in people with HIV
por: Spinelli, Matthew A
Publicado: (2021)

Influence of SARS-CoV-2 Virus Infection on the Course of Psoriasis during Treatment with Biological Drugs
por: Mroz, Magdalena, et al.
Publicado: (2021)

Association between influenza vaccination and SARS-CoV-2 infection
por: Ma'ayeh, Marwan
Publicado: (2023)

Inactivated SARS-CoV-2 vaccine for people with HIV
por: Wolday, Dawit, et al.
Publicado: (2022)

Analysis of selected allergic reactions among psoriatic patients
por: Weryńska-Kalemba, Maria, et al.
Publicado: (2016)

Age groups and spread of influenza: implications for vaccination strategy
por: Hsieh, Ying-Hen
Publicado: (2010)

SARS-CoV-2 and Influenza A virus: Dual diagnostics and vaccines
por: Saied, AbdulRahman A., et al.
Publicado: (2022)

SARS-CoV-2 immunity and vaccine strategies in people with HIV
por: Mullender, Claire, et al.
Publicado: (2022)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Petersen, Eskild, et al.
Publicado: (2020)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

Influenza Vaccination Coverage and (SARS-CoV-2) Seroprevalance in a Fire Department
por: Caban-Martinez, A.J., et al.
Publicado: (2020)

Pregnant people deserve the protection offered by SARS-CoV-2 vaccines
por: Maykin, Melanie M., et al.
Publicado: (2021)

Humoral response to SARS-CoV-2 vaccines in people living with HIV
por: Noe, Sebastian, et al.
Publicado: (2021)

Antibody Response to SARS-CoV-2 Vaccines in People with Severe Obesity
por: Kara, Zehra, et al.
Publicado: (2022)

SARS-CoV-2 vaccines are not associated with hypercoagulability in apparently healthy people
por: Garabet, Lamya, et al.
Publicado: (2022)

Influence of heterogeneous age-group contact patterns on critical vaccination rates for herd immunity to SARS-CoV-2
por: Saldaña, Joan, et al.
Publicado: (2022)

Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity
por: Achdout, Hagit, et al.
Publicado: (2021)

Pilot Study for Immunogenicity of SARS-CoV-2 Vaccine with Seasonal Influenza and Pertussis Vaccines in Pregnant Women
por: Shen, Ching-Ju, et al.
Publicado: (2023)

BRACHIAL NEURITIS FROM THE MRNA SARS-COV-2 AND INFLUENZA VACCINES
por: VanLancker, J., et al.
Publicado: (2022)

CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

Influenza Vaccination and Risk of SARS-CoV-2 Infection in a Cohort of Health Workers
por: Martínez-Baz, Iván, et al.
Publicado: (2020)

A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice
por: Cao, Kangli, et al.
Publicado: (2022)

Understanding Influenza and SARS-CoV-2 Vaccine Hesitancy in Racial and Ethnic Minority Caregivers
por: Baumer-Mouradian, Shannon H., et al.
Publicado: (2022)

Association of Influenza Vaccination With SARS-CoV-2 Infection and Associated Hospitalization and Mortality Among Patients Aged 66 Years or Older
por: Hosseini-Moghaddam, Seyed M., et al.
Publicado: (2022)

The impact of immuno-aging on SARS-CoV-2 vaccine development
por: Connors, Jennifer, et al.
Publicado: (2021)

Comparison of Intake of Food Groups Based on Dietary Inflammatory Index (DII) and Cardiovascular Risk Factors in the Middle-Age Population of Lower Silesia: Results of the PURE Poland Study
por: Szypowska, Alicja, et al.
Publicado: (2023)

SARS-CoV-2 Vaccination Among Incarcerated People: A Barrier to Overcome
por: Fiore, Vito, et al.
Publicado: (2021)

Increasing SARS-CoV-2 vaccination rates among Black people in Canada
por: Eissa, Azza, et al.
Publicado: (2021)

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV
por: Ao, Ling, et al.
Publicado: (2022)

SARS-CoV-2 vaccines tolerability: A perspective by people with multiple sclerosis
por: Di Filippo, Massimiliano, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_78jtkbom6fgl29r1t8kdpltcb4